CONMED Corporation announced solid second quarter results, driven by the strong commitment and exceptional performance of their global team. The company is increasing its guidance for the full year 2021 and now expects revenue between $1.015 billion and $1.035 billion.
Solid second quarter results driven by the global team's performance.
Focus remains on new product innovation.
Strategically investing in commercial and operations teams.
Increased full year 2021 revenue guidance to $1.015 billion - $1.035 billion.
Based on its first six-month results, the Company is increasing its guidance for the full year 2021 and now expects revenue between $1.015 billion and $1.035 billion, compared to its prior guidance of between $1.0 billion and $1.03 billion. The Company now expects full-year 2021 adjusted diluted net earnings per share in the range of $3.15 to $3.25, compared to its prior range of $3.05 to $3.20.